Delivery Order SPE2DB22D3011-SPE2DB24FP8BU
Award Date
12/13/23
Potential Completion Date
12/14/23
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.99, is a delivery order for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp. is a delivery order valued at $1,958.48 for the supply of the pharmaceutical product Wegovy, a 0.25 mg/0.5 ml pen. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 12, 2024. The contract is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,376.21, is for the delivery of the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,817.64, is for the delivery of the drug Wegovy 1.7 mg/0.75 ml pen 0.75ml. This is a Firm Fixed Price delivery order contract with a period of performance ending on March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,950.68, is for the delivery of Wegovy 1.7 mg/0.75 ml pens. This is a firm fixed-price delivery order contract with a completion date of February 7, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $16,390.81, is for the delivery of the drug Wegovy 2.4 mg/0.75 ml pen in 0.75 ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,270.42, is for the supply of the drug Wegovy (0.5 mg/0.5 ml pen, 0.5 ml) to support military healthcare programs. The contract has an ultimate completion date of November 14, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,318.90 firm fixed-price delivery order is for the drug Wegovy 2.4 mg/0.75 ml pen 0.75 ml, with a completion date of March 4, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,540.65, is for the delivery of the drug Wegovy 1 mg/0.5 ml pen in 0.5 ml quantities. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 11, 2025. This award is not associated with a set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,787.18, is a delivery order for the drug Wegovy 1 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price contract with an ultimate completion date of April 10, 2025. The contract is not designated as a set-aside and was awarded on April 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery...